Contract 75N93023F00002
Advanced Bioscience Laboratories, Inc. · Department Of Health And Human Services · October 21, 2022
Advanced Bioscience Laboratories, Inc. was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on October 21, 2022 for $24.26 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Rockville, MD. This is a task or delivery order issued under parent IDIQ 75N93018D00009. The contract has been modified 90 times since the base award It uses cost-plus contract pricing. The most recent modification was on December 19, 2025.
Contract details
- PIID
- 75N93023F00002
- Parent IDIQ
- 75N93018D00009
- Award type
- Delivery Order
- Pricing
- Cost Plus Fixed Fee
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- Place of performance
- Rockville, MD
- First action
- October 21, 2022
- Latest action
- December 19, 2025
Description
CONTRACT ABL HHSN272201800009I ALS3 GMP MASTER CELL BANK PRODUCTION AND FORMULATION DEVELOPMENT
Modification timeline
-
December 19, 2025Mod P00003$0
-
September 29, 2025Mod P00003CLINICAL TRIAL MATERIALS FOR VIRUS VACCINES$0
-
August 27, 2025Mod P00002TASK ORDER AWARD FOR TASK ORDER 4: MECHANICAL REPAIRS$137.0K
-
July 3, 2025Mod P00002MATERIAL AND DATA RECEIPT, STORAGE, SHIPPING, AND INVENTORY$66.2K
-
April 18, 2025Mod P00003EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI FULL TERMINATION$0
-
March 28, 2025Mod P00002$0
-
February 14, 2025Mod P00002CLINICAL TRIAL MATERIALS FOR VIRUS VACCINES$20.7K
-
December 10, 2024Mod P00002PHASE I STUDY OF THE INFECTIVITY, SAFETY AND IMMUNOGENICITY OF TWO RECOMBINANT, LIVE-ATTENUATED, BOVINE/HUMAN, PARAINFLUENZA VIRUS TYPE 3 (B/HPIV3) VECTOR VACCI$0
-
November 19, 2024Mod P00001PHASE I STUDY OF THE INFECTIVITY, SAFETY AND IMMUNOGENICITY OF TWO RECOMBINANT, LIVE-ATTENUATED, BOVINE/HUMAN, PARAINFLUENZA VIRUS TYPE 3 (B/HPIV3) VECTOR VACCI$0
-
October 22, 2024Mod P00002NIAID PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SUPPORT SERVICES FOR VRC/VPP$188.1K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | The Boeing Company | 1 | $4.44B |
| 2 | Advanced Technology International | 9 | $3.35B |
| 3 | Amgen USA Inc | 2 | $774.69M |
| 4 | Siga Technologies, Inc. | 1 | $624.44M |
| 5 | Icon Government And Public Health Solutions, Inc. | 16 | $404.80M |
| 6 | Technical Resources International, Inc. | 19 | $395.29M |
| 7 | Allucent Government Services (Us) Llc | 9 | $384.26M |
| 8 | Mapp Biopharmaceutical, Inc. | 7 | $354.24M |
| 9 | Ppd Development Lp | 18 | $331.02M |
| 10 | Albert B. Sabin Vaccine Institute, Inc. (The) | 2 | $305.87M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93023F00002?
Contract 75N93023F00002 is a federal contract awarded to Advanced Bioscience Laboratories, Inc. by Department Of Health And Human Services on October 21, 2022 for $24.26 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 90 times since the base award.
Who won contract 75N93023F00002?
Advanced Bioscience Laboratories, Inc. won contract 75N93023F00002 from Department Of Health And Human Services.
How much is contract 75N93023F00002 worth?
Contract 75N93023F00002 has obligated $24.26 million to date.